Cargando…
Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity
While pregnancy may accelerate glioblastoma multiforme (GBM) growth, parity and progesterone (P4) containing treatments (ie, hormone replacement therapy) reduce the risk of GBM development. In parallel, low and high doses of P4 exert stimulating and inhibitory actions on GBM growth, respectively. Th...
Autores principales: | Altinoz, Meric A., Ucal, Yasemin, Yilmaz, Muazzez C., Kiris, İrem, Ozisik, Ozan, Sezerman, Ugur, Ozpinar, Aysel, Elmaci, İlhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433824/ https://www.ncbi.nlm.nih.gov/pubmed/32590878 http://dx.doi.org/10.1002/cam4.3223 |
Ejemplares similares
-
pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks
por: Ulgen, Ege, et al.
Publicado: (2019) -
PANACEA: network-based methods for pharmacotherapy prioritization in personalized oncology
por: Ulgen, Ege, et al.
Publicado: (2023) -
Proteomic analysis reveals differential protein expression in variants of papillary thyroid carcinoma
por: Ucal, Yasemin, et al.
Publicado: (2017) -
Zinc protoporphyrin levels in COVID-19 are indicative of iron deficiency and potential predictor of disease severity
por: Kilercik, Meltem, et al.
Publicado: (2022) -
Increased maternal leptin levels may be an indicator of subclinical hypothyroidism in a newborn
por: Karpuzoglu, Hande, et al.
Publicado: (2022)